ProKidney Corp. Class A Ordinary Shares
Symbol: PROK (NASDAQ)
0.00
▼ (-100.00%) -2.600
Company Description:
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $2.6
- Yesterday High: $2.6597
- Yesterday Low: $2.37
- Yesterday Volume: 1.79M
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: ProKidney Corp. Class A Ordinary Shares
- Website: https://www.prokidney.com
- Listed Date: 2022-07-12
- Location: WINSTON-SALEM, NC
- Market Status: Active
- CIK Number: 0001850270
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $326.68M
- Round Lot: 100
- Outstanding Shares: 134.99M
- Asset Type: CS
RECENT FILINGS FOR PROK
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-07-16 | 8-K12B/A | View |
| 2025-07-15 | 8-K | View |
| 2025-07-14 | 8-K | View |
| 2025-07-14 | 424B5 | View |
| 2025-07-11 | 4 | View |
| 2025-07-09 | 4 | View |
| 2025-07-08 | 144 | View |
| 2025-07-08 | 8-K | View |
| 2025-07-07 | EFFECT | View |
| 2025-07-07 | EFFECT | View |
| 2025-07-07 | POS AM | View |
| 2025-07-03 | S-8 POS | View |
| 2025-07-03 | S-8 POS | View |
| 2025-07-03 | S-8 POS | View |
| 2025-07-03 | S-8 POS | View |
| 2025-07-03 | POS AM | View |
Latest News on PROK